Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 21, Pages -Publisher
MDPI
DOI: 10.3390/ijms232113325
Keywords
hepassocin; ER stress; lipid accumulation; liver injury
Funding
- National Natural Science Foundation of China [82070596]
- Natural Science Foundation of Beijing of China [7182124]
- State Key Laboratory of Proteomics [SKLP-K201404]
Ask authors/readers for more resources
Researchers found that HPS transcription is induced by ER stress and fasting/refeeding stimuli in hepatocytes. In vitro experiments showed that HPS deficiency sensitizes hepatocytes to ER stress-related cytotoxicity, while HPS treatment altered these phenotypes. In vivo experiments demonstrated that HPS deficiency exacerbates fasting/refeeding-induced ER stress, while preliminary administration of HPS ameliorates liver steatosis, cell death, and inflammation. The administration of an ER stress inhibitor alleviated steatohepatitis in HPS-deficient mice fed with methionine- and choline-deficient diet.
Hepassocin (HPS) is a hepatokine that has multiple proposed physiological functions. Some of the biological processes in which it is involved are closely related to endoplasmic reticulum (ER) stress, but the role of HPS in the regulation of ER stress remains unclear. Here, we demonstrated that HPS transcription is induced by the protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4) cascade upon ER stress in hepatocytes. Additionally, fasting/refeeding also induced HPS expression in mice liver. The loss of HPS sensitizes hepatocytes to ER stress-related cytotoxicity in vitro, whereas HPS treatment altered these phenotypes. HPS deficiency exacerbates fasting/refeeding-induced ER stress in vivo. The preliminary administration of HPS ameliorates liver steatosis, cell death, and inflammation in mice injected with tunicamycin (TM). The improvement of HPS can be observed even if HPS protein is injected after TM treatment. Furthermore, the administration of an ER stress inhibitor alleviated steatohepatitis in methionine- and choline-deficient (MCD) diet-fed HPS-deficient mice. These results suggest that HPS protects hepatocytes from physiological and pathological ER stress, and that the inactivation of HPS signaling aggravating ER stress may be a novel mechanism that drives the development of steatohepatitis. The protective mechanism of HPS against ER stress in hepatocytes was associated with the regulation of ER calcium handling, and the suppression of calcium influx release from ER upon stressor treatment. Collectively, our findings indicate that HPS may act in a negative feedback fashion to regulate hepatic ER stress and protect hepatocytes from ER stress-related injury. HPS has the potential to be a candidate drug for the treatment of ER stress-related liver injury.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available